Cargando…

Assessment of Patient Reported Outcomes (PROs) in Outpatients Taking Oral Anticancer Drugs Included in the Real-Life Oncoral Program

SIMPLE SUMMARY: Patients receiving oral anticancer agents (OAAs) have a substantial symptom burden. Given the trend toward patient-centered care, the use of patient-reported outcomes (PROs) seems appropriate to secure medication management, and to improve clinical decision-making. The aim of this st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Collomb, Bastien, Dubromel, Amélie, Caffin, Anne Gaëlle, Herledan, Chloé, Larbre, Virginie, Baudouin, Amandine, Cerutti, Ariane, Couturier, Laurence, Maire, Magali, Karlin, Lionel, Maucort-Boulch, Delphine, Huot, Laure, Dalle, Stéphane, Bachy, Emmanuel, Ghesquieres, Hervé, Salles, Gilles, Couraud, Sébastien, You, Benoit, Freyer, Gilles, Trillet-Lenoir, Véronique, Ranchon, Florence, Rioufol, Catherine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833408/ https://www.ncbi.nlm.nih.gov/pubmed/35158928 http://dx.doi.org/10.3390/cancers14030660

Ejemplares similares

Immunomodulatory drugs in multiple myeloma: Impact of the SCARMET (Self CARe and MEdication Toxicity) educational intervention on outpatients’ knowledge to manage adverse effects
por: Périchou, Juliette, et al.
Publicado: (2020)

Adherence to oral anticancer chemotherapy: What influences patients’ over or non-adherence? Analysis of the OCTO study through quantitative–qualitative methods
por: Bourmaud, Aurélie, et al.
Publicado: (2015)

Hypersensitivity to oxaliplatin: clinical features and risk factors
por: Parel, Marie, et al.
Publicado: (2014)

ONCOR: design of the Dutch cardio-oncology registry
por: Kamphuis, J. A. M., et al.
Publicado: (2020)

Pandémie à SARS-COV-2 : implication du pharmacien hospitalier dans la sécurisation de la prise en charge des patients
por: Baudouin, Amandine, et al.
Publicado: (2023)

Chemotherapeutic errors in hospitalised cancer patients: attributable damage and extra costs
por: Ranchon, Florence, et al.
Publicado: (2011)

Comparison of dosimetric characteristics of Siemens virtual and physical wedges for ONCOR linear accelerator
por: Attalla, Ehab M., et al.
Publicado: (2010)

Monte Carlo Simulation of Siemens ONCOR Linear Accelerator with BEAMnrc and DOSXYZnrc Code
por: Jabbari, Keyvan, et al.
Publicado: (2013)

Real life management of patients hospitalized with multiple myeloma in France
por: Dumontet, Charles, et al.
Publicado: (2018)

Dosimetry and evaluating the effect of treatment parameters on the leakage of multi leaf collimators in ONCOR linear accelerators
por: Jabbari, Keyvan, et al.
Publicado: (2016)

Collision indicator charts for gantry‐couch position combinations for Siemens ONCOR and Elekta Infinity linacs
por: Becker, Stewart J., et al.
Publicado: (2013)

Impact of Age on Poly(ADP-Ribose) Polymerase Inhibitor (PARPi)-Induced Lymphopenia: A Scoping Review of the Literature and Internal Analysis of a Retrospective Database
por: Antherieu, Gabriel, et al.
Publicado: (2023)

Tafasitamab for the treatment of relapsed or refractory diffuse large B-cell lymphoma
por: Salles, Gilles, et al.
Publicado: (2021)

Assessment and diffusion of medical innovations in France: an overview
por: Dubromel, Amélie, et al.
Publicado: (2018)

Dose linearity and uniformity of Siemens ONCOR impression plus linear accelerator designed for step-and-shoot intensity-modulated radiation therapy
por: Bhangle, Janhavi R., et al.
Publicado: (2007)

Left ventricular ejection fraction decrease related to BRAF and/or MEK inhibitors in metastatic melanoma patients: A retrospective analysis
por: Berger, Mathilde, et al.
Publicado: (2020)

Decreased survival in patients treated by chemotherapy after targeted therapy compared to immunotherapy in metastatic melanoma
por: Mangin, Marie‐Alix, et al.
Publicado: (2021)

Comparative optimism in models involving both classical clinical and gene expression information
por: Truntzer, Caroline, et al.
Publicado: (2008)

Health-related quality of life in cancer immunotherapy: a systematic perspective, using causal loop diagrams
por: Beaulieu, Elizabeth, et al.
Publicado: (2022)

The importance of experimental models in interventional cardiology. An illustration in coronary bifurcation stenting
por: Derimay, Francois, et al.
Publicado: (2022)

A randomized trial to evaluate the impact of exercise-based cardiac rehabilitation for the prevention of chemotherapy-induced cardiotoxicity in patients with breast cancer: ONCORE study protocol
por: Díaz-Balboa, Estíbaliz, et al.
Publicado: (2021)

Diagnostic Concordance in Tertiary (Dermatologists-to-Experts) Teledermoscopy: A Final Diagnosis-Based Study on 290 Cases
por: Marchetti, Anne, et al.
Publicado: (2020)

Phase I dose-escalation study of aflibercept in combination with docetaxel and cisplatin in patients with advanced solid tumours
por: Freyer, G, et al.
Publicado: (2012)

World‐wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma
por: de Martel, Catherine, et al.
Publicado: (2015)

Prognostic factors for tumour response, progression-free survival and toxicity in metastatic colorectal cancer patients given irinotecan (CPT-11) as second-line chemotherapy after 5FU failure
por: Freyer, G, et al.
Publicado: (2000)

Pros & Cons
por: Herr, Yeek
Publicado: (2011)

Conditions for the Implementation of a Patient Education Program Dedicated to Cancer Patients Treated by Oral Anticancer Therapy
por: Verot, Elise, et al.
Publicado: (2020)

Percutaneous atrial septal defect occlusion through thrombosed inferior vena cava filter
por: Rakotonoel, Radotseheno Rolland, et al.
Publicado: (2021)

Collaborative work in a complex case of Fontan for treating intra-atrial reentrant tachycardia and severe aortic stenosis: a case report
por: Acatrinei, Camélia, et al.
Publicado: (2023)

Supercollider: Pros and cons
Publicado: (1993)

The Pros of Not Being Competitive
por: MUTEL, VINCENT, et al.
Publicado: (2007)

Circumcision: Pros and cons
por: Burgu, Berk, et al.
Publicado: (2010)

Puzzles for Programmers and Pros
por: Shasha, Dennis
Publicado: (2007)

The pros and cons of degeneracy
por: Goaillard, Jean-Marc, et al.
Publicado: (2014)

Malondialdehyde Adduct to Hemoglobin: A New Marker of Oxidative Stress Suitable for Full-Term and Preterm Neonates
por: Cipierre, Cécile, et al.
Publicado: (2013)

Adduct of Malondialdehyde to Hemoglobin: A New Marker of Oxidative Stress That Is Associated with Significant Morbidity in Preterm Infants
por: Cipierre, Cécile, et al.
Publicado: (2013)

Vascular Events and Carotid Atherosclerosis: A 5-Year Prospective Cohort Study in Patients with Type 2 Diabetes and a Contemporary Cardiovascular Prevention Treatment
por: Vouillarmet, Julien, et al.
Publicado: (2019)

Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines)()
por: Slimano, Florian, et al.
Publicado: (2020)

Machine learning with PROs in breast cancer surgery; caution: Collecting PROs at baseline is crucial
por: van Egdom, Laurentine S. E., et al.
Publicado: (2020)

Medical dramas – the pros and the cons
por: Aboud, Khalid Al
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_liv5bnp6on6n61v2um2t62fhqa